Although most B-RAF mutants display elevated kinase activity compared to the B-RAFWT, four cancer-derived mutants have reduced kinase activity: B-RAFG466E, B-RAFG466V, B-RAFG596R and B-RAFD594V [3,4]. The gene discussed is BRAF; the disease is cancer.